The rising popularity of GLP-1 weight loss medications is prompting employers to reassess their health plans. While these drugs are effective for weight loss and diabetes management, they come with high costs. Employers face challenges in covering these medications due to their expense, with plan sponsor costs doubling over the past two years. As a result, many companies are focusing on comprehensive weight loss strategies, including nutrition and mental health support, and implementing cost-control measures for GLP-1 coverage to manage expenses effectively.

Learn more in the full article featuring Employee Benefits Pharmacy Director Nathan Cassin, and Travis Dent, Sr. Vice President, Employee Benefits.